China’s National Development and Reform Commission (NDRC) has issued a rare and landmark veto against the acquisition of the AI startup Manus by Meta. The decision marks the first time an artificial intelligence deal has been publicly halted under the 2020 Foreign Investment Security Review Measures. This move effectively blocks the U.S. social media giant from absorbing what was widely considered one of China’s most promising AI breakthroughs in recent years.
Manus, originally developed by the domestic firm Butterfly Effect, gained global notoriety last year for its advanced 'AI Agent' technology. To facilitate a smoother exit and navigate the increasingly complex web of U.S.-China tech restrictions, the company attempted a maneuver known locally as 'Jin Chan Tuo Qiao' or 'shedding the golden cicada's skin.' This involved relocating its headquarters to Singapore, rebranding as Butterfly Effect Pte, and liquidating its Chinese presence while moving core technical staff abroad.
Beijing’s regulatory intervention signals that a change in corporate registration is no longer sufficient to bypass Chinese jurisdiction. The NDRC’s scrutiny focused not on the Singaporean entity itself, but on the preceding chain of events where intellectual property, core research capabilities, and training data were transferred out of China. By retroactively applying security frameworks to this transition, regulators have sent a clear message that technology 'born and raised' in China remains subject to Chinese export controls.
The decision comes amidst a fierce global race for AI supremacy, where 'AI Agents' are viewed as the next frontier of productivity. Chinese authorities are increasingly concerned about a 'brain drain' where domestic innovation, fueled by local infrastructure and engineering talent, is harvested by American tech titans. Officials argue that allowing such exits would hollow out China's internal innovation ecosystem and allow the U.S. to 'cherry-pick' the best of Chinese research while simultaneously denying China access to high-end chips.
While the ruling is a significant blow to the founders' hopes for a $2 billion liquidity event, it highlights the 'exit trap' now facing Chinese tech entrepreneurs. For years, Singapore served as a neutral staging ground for Chinese startups seeking global capital. However, as Beijing tightens its grip on 'critical technologies,' the path from a Chinese lab to a Silicon Valley balance sheet has become fraught with legal and political risks that no amount of corporate restructuring can easily mask.